Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development - N Ferrari - Books - John Wiley & Sons Inc - 9781118537336 - July 31, 2018
In case cover and title do not match, the title is correct

Oligonucleotide-Based Drugs and Therapeutics: Preclinical and Clinical Considerations for Development

Price
$ 219.49
excl. VAT

Ordered from remote warehouse

Expected to be ready for shipping Jul 1 - 13
Add to your iMusic wish list

Antisense-based drugs are part of a growing number of pharmaceutical and biotech programs to treat diseases including cancer, diabetes, and ALS. Reviewing fundamentals and offering guidelines for drug discovery and development, this book is a practical guide from the safety assessment to clinical experience with antisense oligonucleotides.


576 pages

Media Books     Hardcover Book   (Book with hard spine and cover)
Released July 31, 2018
ISBN13 9781118537336
Publishers John Wiley & Sons Inc
Pages 576
Dimensions 160 × 231 × 33 mm   ·   898 g
Language English  
Editor Ferrari, Nicolay
Editor Seguin, Rosanne

Mere med samme udgiver